GPR160 is a potential biomarker associated with prostate cancer.
Guo W, Zhang J, Zhou Y, Zhou C, Yang Y, Cong Z, Dong J, Yang D, Dai B, Wang MW.
Guo W, et al. Among authors: zhou y, zhou c.
Signal Transduct Target Ther. 2021 Jun 25;6(1):241. doi: 10.1038/s41392-021-00583-7.
Signal Transduct Target Ther. 2021.
PMID: 34168114
Free PMC article.
No abstract available.